Chen Peng, Jiaxin Li, Nan Wang, Xinyue Zhang, Wen Zhang, Zhirui Li, Keyi Zhang, Yangchaowei Ji, Wei He, Yan Li
{"title":"可追踪的纳米颗粒与线粒体靶向丙酮酸铜诱导铜增生,以增强三阴性乳腺癌治疗小鼠模型。","authors":"Chen Peng, Jiaxin Li, Nan Wang, Xinyue Zhang, Wen Zhang, Zhirui Li, Keyi Zhang, Yangchaowei Ji, Wei He, Yan Li","doi":"10.1039/d5mh01047k","DOIUrl":null,"url":null,"abstract":"<p><p>We develop pyruvate with good biocompatibility and mitochondria-targeting ability as a copper ionophore (pyruvate-Cu). To further address its drawbacks, traceable nanoparticles are constructed to deliver pyruvate-Cu for triple negative breast cancer (TNBC) treatment. <i>In vitro</i> and <i>in vivo</i> results demonstrate that this work provides an efficient platform for enhanced TNBC therapy.</p>","PeriodicalId":87,"journal":{"name":"Materials Horizons","volume":" ","pages":""},"PeriodicalIF":10.7000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple-negative breast cancer therapy in a mouse model.\",\"authors\":\"Chen Peng, Jiaxin Li, Nan Wang, Xinyue Zhang, Wen Zhang, Zhirui Li, Keyi Zhang, Yangchaowei Ji, Wei He, Yan Li\",\"doi\":\"10.1039/d5mh01047k\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We develop pyruvate with good biocompatibility and mitochondria-targeting ability as a copper ionophore (pyruvate-Cu). To further address its drawbacks, traceable nanoparticles are constructed to deliver pyruvate-Cu for triple negative breast cancer (TNBC) treatment. <i>In vitro</i> and <i>in vivo</i> results demonstrate that this work provides an efficient platform for enhanced TNBC therapy.</p>\",\"PeriodicalId\":87,\"journal\":{\"name\":\"Materials Horizons\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":10.7000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Materials Horizons\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1039/d5mh01047k\",\"RegionNum\":2,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Horizons","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1039/d5mh01047k","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple-negative breast cancer therapy in a mouse model.
We develop pyruvate with good biocompatibility and mitochondria-targeting ability as a copper ionophore (pyruvate-Cu). To further address its drawbacks, traceable nanoparticles are constructed to deliver pyruvate-Cu for triple negative breast cancer (TNBC) treatment. In vitro and in vivo results demonstrate that this work provides an efficient platform for enhanced TNBC therapy.